[Pharmacodynamic aspects of drug interactions--receptor affinity and pharmacologic interactions].
D000262:Adenylyl Cyclases / Q000502:physiology; D001665:Binding Sites; D002118:Calcium / Q000502:physiology; D002301:Cardiac Glycosides / Q000502:physiology; D003035:Cobalt / Q000502:physiology; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004347:Drug Interactions; D006801:Humans; D006980:Hyperthyroidism / Q000378:metabolism; D008274:Magnesium / Q000502:physiology; D009206:Myocardium / Q000378:metabolism; D011188:Potassium / Q000502:physiology; D011972:Receptor, Insulin / Q000502:physiology; D011943:Receptors, Adrenergic, beta / Q000502:physiology; D011955:Receptors, Drug / Q000502:physiology*; D011957:Receptors, Opioid / Q000502:physiology
D002301:Cardiac Glycosides; D004071:Digitalis Glycosides; D011943:Receptors, Adrenergic, beta; D011955:Receptors, Drug; D011957:Receptors, Opioid; D003035:Cobalt; D011972:Receptor, Insulin; D000262:Adenylyl Cyclases; D008274:Magnesium; D011188:Potassium; D002118:Calcium
Pharmakodynamische Aspekte medikamentöser Wechselwirkungen--Rezeptorbesetzung und pharmakologische Interaktionen.